Inventor · disambiguated record
Andreas Ritzen
Also filed as: RITZEN ANDREAS · RITZÉN ANDREAS
20 granted patents·10 pending applications·49 citations·filing 2002–2025
93Inventor score
Files withLUNDBECK & CO AS H10LEO PHARMA AS4MONTE ROSA THERAPEUTICS AG4MONTE ROSA THERAPEUTICS INC4SCRIPPS RESEARCH INST3
Top patents by PatentIndex Score
30 records- 0186US7501414B2Substituted morpholine and thiomorpholine derivativesLUNDBECK & CO AS H·Filed 2005·Granted Mar 10, 2009·8 cites·15 claims
- 0285US8133897B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZEN ANDREAS·Filed 2009·Granted Mar 13, 2012·10 cites·16 claims
- 0382US7812023B2Methods of using substituted morpholine derivativesLUNDBECK & CO AS H·Filed 2009·Granted Oct 12, 2010·4 cites·10 claims
- 0482US7632835B2Substituted morpholine and thiomorpholine derivativesLUNDBECK & CO AS H·Filed 2009·Granted Dec 15, 2009·4 cites·15 claims
- 0579US8865711B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsRITZÉN ANDREAS·Filed 2012·Granted Oct 21, 2014·2 cites·24 claims
- 0677US8012962B2Substituted thiomorpholine derivativesLUNDBECK & CO AS H·Filed 2009·Granted Sep 6, 2011·2 cites·14 claims
- 0774US12257247B2Targeted degradation of VAV1MONTE ROSA THERAPEUTICS AG·Filed 2024·Granted Mar 25, 2025·0 cites·12 claims
- 0872US9018217B2Phenylimidazole derivatives as PDE10A enzyme inhibitorsLUNDBECK & CO AS H·Filed 2014·Granted Apr 28, 2015·1 cites·29 claims
- 0971US12391663B2Isoindolinone compoundsMONTE ROSA THERAPEUTICS AG·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 1071US8841297B2Phenylimidazole derivative as PDE10A enzyme inhibitorRITZÉN ANDREAS·Filed 2010·Granted Sep 23, 2014·3 cites·12 claims
- 1171US7601870B2Substituted aniline derivativesLUNDBECK & CO AS H·Filed 2005·Granted Oct 13, 2009·1 cites·9 claims
- 1270US7169930B2Analogs of epothiloneSCRIPPS RESEARCH INST·Filed 2003·Granted Jan 30, 2007·4 cites·5 claims
- 1368US7358266B2Cyclopropyl and cyclobutyl epothilone analogsSCRIPPS RESEARCH INST·Filed 2002·Granted Apr 15, 2008·5 cites·23 claims
- 1466US7906537B2Substituted p-diaminobenzene derivativesLUNDBECK & CO AS H·Filed 2004·Granted Mar 15, 2011·3 cites·19 claims
- 1562US7368472B21,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous systemLUNDBECK & CO AS H·Filed 2003·Granted May 6, 2008·2 cites·20 claims
- 1660US2024299559A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1759US2010063044A1Substituted aniline derivativesLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 1858US9592230B2Substituted imidazoles as PDE10A inhibitorsH LUNDBECK AS·Filed 2015·Granted Mar 14, 2017·0 cites·10 claims
- 1957US2024308976A1Compounds that mediate protein degradation and uses thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2057US2024294495A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2156US2024317706A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2252US2025205219A1Targeted degradation of vav1MONTE ROSA THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 2351US2025263395A1Compounds that mediate protein degradation and methods of use thereofMONTE ROSA THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 2451US2006293527A1Analogs of epothiloneSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 2548US10703751B2Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
- 2647US10799507B25-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitorsLEO PHARMA AS·Filed 2018·Granted Oct 13, 2020·0 cites·20 claims
- 2746US8299075B2Substituted thiomorpholine derivativesWENZEL TORNOE CHRISTIAN·Filed 2011·Granted Oct 30, 2012·0 cites·11 claims
- 2845US2021269447A1Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2019·Application pending·0 cites
- 2943US10851116B2Bicyclic amines as novel JAK kinase inhibitorsLEO PHARMA AS·Filed 2018·Granted Dec 1, 2020·0 cites·20 claims
- 3042US2009118285A1Use of kcnq-openers for treating or reducing the symptoms of schizophreniaLUNDBECK & CO AS H·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Ritzen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →